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Despite the hard times COVID-19 has imposed on us, the Biomedical Journal strives to pro-
vide fresh and compelling reading material - to be enjoyed safely from home. In this issue,
we glance behind the scenes of dental stem cell preservation for potential therapeutic use,
and discover that cancer cells hijack podoplanin expression to induce thrombosis. More-
over, we learn how the helicase DDX17 promotes tumour stemness, how genetic defects in
meiosis and DNA repair cause premature ovarian insufficiency, and that the brain-derived
neurotrophic factor is associated with several psychiatric diseases. Further accounts relate
the role of miR-95-3p in colorectal cancer, the protective power of eggplants against
mercury poisoning, and the predictive value of inhibin A for premature delivery. Finally,
the very rare case of adenoid cystic carcinoma in the external auditory canal receives some
attention, and we get to read up on how 3D imaging and modelling combines functional
and aesthetic repair of cleft lip and palate cases.Spotlight on reviews
Bargain with the tooth fairy e the saving accounts for
dental stem cells
There is a clear linguistic split in Europe and the Americas,
regarding the belief in supernatural entities who are in charge
of baby teeth retrieval in exchange for cash.
Scandinavian countries, where the myth probably origi-
nated, as well as Slavic and Germanic-language nations rely
on the tooth fairy,1 whereas countries with Romance lan-
guages outsourced the job to a mouse, sometimes just




ublishing services by Else
s/by-nc-nd/4.0/).(Hispanic countries). In all cases, the tooth has to be placed
under the pillow before going to sleep and will have been
traded for money by the next morning. Asian beliefs focus
more on the future of the adult tooth to come: in China for
instance, a baby tooth from the upper jaw has to be thrown
under the bed or buried, and one from the lower jaw thrown
onto the roof, for the new tooth to grow quickly and straight
into the right direction.2 Funnily enough, mice are an excep-
tion among mammals, as they are monophyodonts and thus
do normally not shed any teeth, which has made them an
interesting model to investigate the evolution of replacement
teeth [1]. Mammals for their part are the exception among
vertebrates, which are usually polyphyodonts, meaning thatarch & Innovation Centre, Anders Lund Group, Ole Maaløes Vej 5
vier B.V. This is an open access article under the CC BY-NC-ND
Fig. 1 The main steps of dental pulp stem cell preservation for potential later therapeutic use. Various companies offer the
isolation of dental pulp stem cells from deciduous or adult teeth, followed by expansion, quality control and cryopreservation
for an extended period of time. The expected used would be autologous tissue repair in the oral cavity, and eventually
regeneration of other tissues depending on technical and technological advancements. Figure kindly provided by Zeitlin
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teeth all throughout their lifetime [2]. Hence, humans possess
amore complex, but only diphyodont dentition: a trial version
of deciduous teeth, replaced around age 6 by a permanent set.
Loss of any component of the latter, through mechanical
injury, infection, or age entails the need for artificial replace-
ment, and usually steep medical bills.
In these circumstances, Zeitlin et al. present a refreshing
account about companies offering the extraction, expansion,
and preservation of dental stem cells, highlighting scientific
facts, clinical evidence, and the practicalities of the service [3].
The authors start with a comprehensive overview of the
hierarchy of stem cells, from totipotent e capable of gener-
ating all embryonic and extraembryonic tissues e to multi-
potent, also known as adult stem cells (ASCs), a
heterogeneous group of cells with a limited potential to pro-
liferate and to give rise to several cell types of a given organ.
Without doubt, it is the discovery of induced pluripotent
stem cells (iPSCs) in 2006 that mainly triggeredmassive hopes
for autologous tissue repair [4]. After all, the theory sounds as
straightforward as alluring, given that terminally differenti-
ated cells can be reprogrammed to an embryonic stem cell-
like state, and subsequently differentiated into the needed
cell type. As it turned out however, the official availability of
this kind of technology might take some time [5].
Somehow, ASCs inherited these therapeutic hopes, and
without delay, businesses sprang to life, offering the storage of
precious potential replacement parts. Given that both the
amount and the differentiation potential of ASCs seem to
decline with age [6], the trend is to harvest the earliestavailable cell material with the largest differentiation spec-
trum. The prime examples are haematopoietic stem cells and
mesenchymal stem cells (MSCs) derived from the umbilical
cord [7,8]. Notably the latter are currently used in countless
clinical trials [9], and kicked off the tissue cryobanking business.
As a consequence, in 2018, over 450 companies worldwide
offered cord blood banking services.3 Securing this cell source
however is possible only during an extremely short time
window and relies on the individual's parents' sole decision.
Therefore, more and more alternative ASC sources have been
explored over the recent years. A good example was discussed
in a recent issue of the Biomedial Journal, where we discovered
the promising potential of locally derivedMSCs derived for the
repair of anterior cruciate ligaments [10,11].
Here, the authors acquaint the reader with the different
classes of ASCs found in the oral cavity: in a nutshell, the two
main ones are derived from the dental pulp of either baby
teeth, bound to be shed anyways, or adult teeth, accessible for
example after wisdom tooth removal.
One very interesting feature of dental pulp stem cells is
that they originate from the neural crest, itself of ectodermal
origin. Neural crest cells are a fascinating ingredient of
embryogenesis, in view of their unique ability to migrate into
almost any tissue, and to participate in its development [12],
and species-specific pattern [13]. In the current context, they
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which can derive from two different embryonic germ layers -
mesoderm and ectoderm - and explain why dental pulp stem
cells can give raise to functional neurons [14].
Importantly, Zeitlin and colleagues point out the discrep-
ancy between the exuberant promises featured by the internet
regarding the therapeutic potential of dental pulp stem cells,
and the available clinical evidence. Admittedly, the cells flirt
with the pluripotent end of the ASC spectrum, as they have
given rise to derivatives of all three embryonic germ layers in a
chaotic manner in vitro or as teratomas, and could be directed
into the typical progeny of MSCs plus neurons and ondonto-
blasts [15]. Nonetheless, the authors estimate that their best
chances for concrete use will be the direct repair of specific
dental lesions or the indirect improvement of tissue regener-
ation through immunomodulation [16].
The second part of the review details the practical process
of tooth banking, a service offered by at least 15 companies
(Fig. 1). After a frankly entertaining section dedicated to
various recommended storage options for tooth transport,
from cow milk to sports drinks, the authors speculate on the
most likely protocols for stem cell isolation. The two main
possibilities are mechano-enzymatic dissociation into single
cell populations and tissue outgrowth, with the latter maybe
reminding the reader of one early and original way of
reprogramming keratinocytes from plucked hair directly in a
dish [17]. Tests for viability and pluripotency can vary between
companies, while there is little doubt on the efficiency of
common freezing protocols, preservation in liquid nitrogen,
and finally the possibility to recover functional cells after
prolonged freezing.
Remains the obvious debate of the cost aspect. Or rather,
the financial investment versus the realism degree of the
promised benefits. From this point of view, tooth banking
might be the safe certificates of deposit on the human body
parts stock market, especially when compared to much more
eccentric options: about six different companies, most of
them located in the Unites States, offer the cryogenic pres-
ervation of either the entire body or the severed head after
the client has been declared clinically dead, for a modest fee
ranging from $28 000 to $200 000, and absolute faith into
some distant future technologies to reanimate them.4
Although the idea is resourcefully described as an “ambu-
lance through time” by the director of one institute,5 neither
the fields of science nor economy grant it any support - the
first because of the massive damage current cryopreserva-
tion does notably to the brain, the second based on the fact
that companies very rarely survive more than a hundred
years.
Determined to counter at least the first factor, the company
Nectome founded in 2018 (and not a Black Mirror episode)
opted for the life-incompatible but near-atomic, chemical
preservation of the brain through cross-linking, assuming that
the distant future technologies will be able to scan the4 http://reillytop10.com/previous-lists/2017-list/reanimating-
cryonics/.
5 https://www.youtube.com/watch?
v¼zRxI0DaQrag&feature¼youtu.be&t¼1034.structure and infer all necessary information to simulate the
late individual, memories included.
Clearly, fiction has come a long way since the tooth fairy -
yet the latter seems still the more reliable ally when it comes
to tissue replacement.Spotlight on original articles
Sticking together e how cancer cells manipulate platelet
aggregation
Not only do tumour cells hijack countless intracellular cell
signalling pathways, but they equally ensnare their sur-
roundings, coaxing their microenvironment into a suitable,
supportive niche [18], and exerting long-range influence on
the remaining organism by shedding vesicles into the circu-
lation [19]. On these grounds, the collection of molecules
displayed on the surface of cancer cells is of particular inter-
est, evidently in order to recognise and target them [20], but
also to understand how they communicate with neighbouring
cells and escape the immune system [19]. Multiple compo-
nents of the cancer cell surface have already been thoroughly
investigated, such as the glycocalix [21], integrins [22], and cell
surface receptors [23].
Lee et al. have set their sights on podoplanin (PDPN) [24], a
transmembrane mucin-like glycoprotein required for the
correct development of lung alveoli, heart, and lymphatic
system, to cite only a few functions [25]. The major particu-
larity of PDPN though is that it does not possess any functional
domains or enzymatic activities on its own. Instead, it exerts
its “activities” by interacting with numerous molecules pre-
sent either on the same cell surface as PDPN, or on neigh-
bouring cells. Examples include the C-type lectin-like
receptor-2 (CLEC-2), CD44, or protein kinase A (PKA) [26]. In
particular, activation of CLEC-2 by PDPN on lymphatic endo-
thelial cells or fibroblastic reticular cells triggers platelet
activation and aggregation, which is necessary for the accu-
rate separation of blood and lymphatic vessels [27], and ce-
rebrovascular patterning [28].
Once development achieved, PDPN probably participates in
the maintenance of endothelial integrity [27], but is also
frequently upregulated on tumour cells, or on immune cells,
fibroblasts, and epithelial cells during inflammation [25]. In
the cancer setting, PDPN is said to promote migration, inva-
sion, metastasis, proliferation, and clonal capacity [25,26], yet
the underlying mechanisms are forcefully dependent on its
binding partners. Notably, little is known about PDPN's ability
to induce platelet aggregation in a tumour context.
Lee et al. concentrate here on oral squamous cell carci-
noma (OSCC), a highly lethal cancer type with over 300 000
new cases per year and 50% of patients dying within 5 years
[29]. The authors confirm the expression of PDPN in five out of
nine OSCC cell lines, before focusing on the commonly used
OECM-1 line. One interesting observation is that the average
PDPN levels are not due to a homogeneous expression, but
that the cell population can be further separated into Pþ cells
with high and P- with low or absent PDPN levels. This
immediately echoes the frequent detection of cellular het-
erogeneity within the same tumour, with stem cell-like
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researched - and controversial - case [30].
Stable and efficient knock-down by small hairpin RNAs
(shRNA) of PDPN is subsequently achieved in the Pþ fraction,
with no impact on cell morphology, and surprisingly also no
alteration of cell proliferation, in contrast to some previous
reports [25,26]. Nevertheless, as PDPN function depends on its
interaction partners, substantial differences in phenotypes
could be due to different triggered pathways.
Unlike the absence of an effect on proliferation however,
the knock-down of PDPN significantly reduces in vitro invasion
and migration abilities, in accordance with other studies.
Aggregation of human washed platelets was only observed
after substantial overexpression of PDPN in Pþ cells, raising
again the question if other factors are required for the mole-
cule to deploy its full potential, especially as aggregation takes
place with platelet and cancer cells, and is inhibited by PDPN
knock-down. In due course, the authors turn in vivo, using a
real-time monitored ectopic xenograft model in immuno-
compromised mice. The previous observation that PDPN
expression does not have an effect on proliferation holds true
in the mouse model, as knock-down of the protein in Pþ cells
does not change tumour growth and metastasis compared to
the mock shRNA. Nonetheless, survival is considerably
shortened in the control compared tomice injectedwith PDPN
knock-down cells. Notably, these animals showed platelet
infiltration into the primary tumour, intravascular platelet
aggregation, and presented multiple signs of increased intra-
vascular thrombosis activity.
Finally, the authors replicate most of the previous results,
this time by overexpressing PDPN in the P- population. The
high-level PDPN cells induce platelet aggregation in vitro,
shorten the survival of mice in a xenograft model, and lead to
platelet accumulation inside the tumour and blood vessels.
However, no significant increase in thrombosis markers is
noted, leading once again to the possibility that an unknown
co-factormodulates PDPN function. Lee et al. hypothesise as a
matter of fact that the Pþ and P- subpopulations differ inmore
ways than their PDPN expression levels, and that the P- frac-
tion lacks the partner required for PDPN to trigger coagulation.
The downstream effects of PDPN-mediated thrombosis are
not clear yet. One could speculate though that platelet ag-
gregation would facilitate the slowing down of circulating
tumour cells (CTCs), and their subsequent extravasation and
invasion of distant tissues. Lee et al. did not observe a corre-
lation of metastasis and PDPN in their specific setting, but as
the field of CTC biology is only in its beginnings e see the
previous issue of the Biomedical Journal [31,32]e the hypothesis
certainly deserves further investigation.Also in this issue
Reviews
Back to the origins - hypoxia shifts DDX17 function from
miRNA biogenesis to promoting cancer stemness
Cancer stem cells (CSCs) are the controversial and dreaded
joker card of any tumour, as they are held responsible for
augmented growth, invasion, resistance to treatment, andfinally relapse after seemingly successful eradication of the
primary tumour [33].
Through high-jacking of the organism's normally tightly
controlled pluripotency pathways, cancer cells acquire prop-
erties such as immortality, high proliferation rates, and
increased resistance to damage or harsh environments, such
as hypoxia. Moreover, stemness gain is also associated with
epithelial mesenchymal transition, and thus increased cell
mobility and invasion properties [34]. All components of the
pluripotency pathways have been found to be mis-
appropriated by cancer, including proteins, long noncoding
RNAs [35], and of course microRNAS (miRNAS).
Kou-Juey Wu dedicates a detailed review to an extremely
polyvalent component of miRNA biogenesis and regulation,
the microprocessor cofactor DEAD-box helicase 17 (DDX17),
and its implication in promoting cancer stemness under
hypoxic conditions [36]. The author elaborates on the CSC
concept and recapitulates the essentials of miRNA biogenesis,
regulation, and the established connection between miRNA
deregulation and tumorigenesis, as well as the many roles of
DDX17 in all of these. Subsequently, it is explained how hyp-
oxia shifts the DDX17 activity by K63-linked poly-
ubiquitination from cytoplasmic miRNA biogenesis to
various nuclear functions. This decreases the production of
anti-stemness miRNAs, while increasing the expression of
pluripotency factors, as DDX17 features as a transcription co-
factor and promotes activating epigenetic changes.
Fair share e how defective meiosis and DNA repair cause
female infertility
Accurate cell division and distribution of genetic information
is rather important for any cell type, for germ cells however,
specifically undergoing meiosis, it is a matter of life and death
[37]. Therefore, it does not come as a surprise that defects of
the meiotic apparatus and DNA repair systematically lead to
infertility. These shortcomings can be caused by pathogens,
autoimmune diseases, environmental factors, or have a ge-
netic base [38].
In his review, Reiner Veitia focuses on how mutations
affecting genes involved inmeiosis and DNA repair can lead to
premature ovarian insufficiency (POI), one of the principal
causes of female infertility [39]. Stressing the powerful com-
bination of high throughput sequencing with classical ge-
netics in consanguineous families, the author provides and
exhaustive description of genetic variants connecting POI and
meiotic chromosome pairing, as well as DNA recombination
and repair.
Minds and molecules e associations of BDNF with mental
disorders
Deciphering the underlying molecular causes of psychiatric
disorders is an ongoing Herculean task, given the heteroge-
neity of the disorder spectra, just as much as the multifacto-
rial nature of their causes, embracing genetics, epigenetics
and environment. High throughput eomics, from tran-
scriptomics to metabolomics, were expected to shed some
light onto the matter, and have definitively delivered some
clues, yet high-dimensionality data analytics on huge datasets
are required in order to take into account the complexity of
the system [40].
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(BDNF) in psychiatric diseases can be considered an educated
guess, given the importance of the protein in countless
developmental and functional processes of the mammalian
brain [41].
Here, Lin and Huang have compiled a comprehensive se-
lection of studies relating the possible connection of BDNF
with schizophrenia, major depressive disorder, and bipolar
disorder [42]. They thoroughly discuss associations with
either protein or mRNA abundance, single nucleotide poly-
morphisms, or epigenetic modifications of the BDNF locus,
and stress at the occasion the importance of additional pa-
tient stratification by gender, ethnicity, disease stage or phase,
and physiological components.6 https://www.accoi.org/faq/acc-statistics/.Original articles
Janus-faced small molecules - miR-95-39 acts as a tumour
suppressor in colorectal cancer
Literature on microRNAs (miRNAs) levels as highly specific
biomarkers and therapeutic targets for all cancer types has
recently exploded [43,44], and several miRNA replacement
therapies are currently at clinical trial stages [45]. Nonethe-
less, just as much as different cancer types display highly
divergent properties, and strong heterogeneity even among
the same tumour class, the role of a certain miRNA can be
contrasting depending on the context.
MiR-95-3p has already been studied in many cancers, and
been found to act either as an oncogene [46], or as a tumour
suppressor [47], depending on the dominant mechanism.
Hong et al. extend the list by investigating here the role of
miR-95-3p in colorectal cancer (CRC) [48]. The authors show
that miR-95-3p expression is lower in CRC cell lines and
tumour tissue compared to normal intestinal cells or adjacent
tissue. Moreover, patients with the lowest miR-95-3p expres-
sion levels displayed worse recurrence survival and overall
survival rates. Overexpression of miR-95-3p inhibited cell
proliferation and mobility of CRC cells in vitro, as well as
tumour growth and metastasis in a mouse xenograft model,
and improved the survival of the latter. The hepatoma-
derived growth factor (HDGF) was identified in silico as a pu-
tative target for miR-95-3p, and subsequently validated by
several assays. According to these results, miR-95-3p qualifies
as a tumour suppressor in CRC, and could be a reliable prog-
nostic biomarker from early stages on, while HDGF might
represent a therapeutic target.
Eat your vegetables e eggplant extract reduces mercury
chloride toxicity in testes
The expression “to be mad as a hatter” potentially stems from
the symptoms of mercury poisoning, as mercuric nitrate was
routinely used to separate the fur from the pelt in the felt
hatting industry [49]. The curious, liquid metal, commonly
known as quicksilver, was used during centuries formedicinal
and industrial applications, from magico-religious rituals to
metal recovery processes, or to treat syphilis [50]. It took quite
some time to recognise the highly harmful effects of mercury,notably on the nervous system [51] - as proven by Minamata
disease, the neurological disorder caused by methylmercury
released into the industrial wastewater by the Japanese
Chisso chemical factory until 1968 [52]. Nowadays, the main
sources of human exposure are dental amalgams, occupa-
tional exposure, or contaminated fish [53]. Eggplants, on the
opposite, are not only delicious on pizza, but fully loaded with
health benefits in the form of vitamins, phenolics and anti-
oxidants [54]. Moreover, as shown here by Adelakun et al.,
feeding rats whole eggplant extract in parallel with mercury
chloride reduces significantly the testicular toxicity of the
latter by boosting the organism's antioxidant system [55].
Early warnings for early babies e inhibin A could be used as
a marker for preterm birth risk
Preterm birth (PTB) designates delivery earlier than 37 weeks of
gestation and is the leading cause of neonatal death andamajor
risk factor for death before age 5, as well as developmental dis-
abilities [56]. Early detection of preterm labour is key for
adequate prevention and management, however, the underly-
ing causes are complex and multi-factorial. Known risk factors
encompass infections, stress, multiple gestations, or maternal
bodyweight - yet about two-thirdsof PTBcases lack an apparent
predisposition [57]. Measurement of cervical length is so far one
of themost reliable and cost-effectivemethods [58], but over the
past decade, much effort was made to additionally identify
biomarkers predictive of spontaneous PTB inmaternal blood at
earlier stages [59,60]. Until now, it has been considered quite
unlikely that a single test would be sufficient for predicting PTB
[61], however data gathered by Huang and colleagues strongly
indicate that maternal inhibin A levels from the second
trimester are a good candidate [62]. Inhibin is a glycoprotein and
probably named during a peak moment of pragmatism, as it
inhibits follicle-stimulating hormone (FSH) secretion, in unsur-
prising contrast to activin [63]. So far, it has been used as a
biomarker for ovarian cancer [64] and Down syndrome [65].
Huang et al. show here that inhibin A levels over 2.25 are sta-
tistically significant in their associationwithpreterm labour [62],
andmight thus be an early clue prompting closer monitoring of
the patients.
Don't turn a deaf ear to adenoid cystic carcinoma in the
external auditory canal
Adenoid cystic carcinoma (ACC) is a rare form of cancer with
an approximate incidence rate of 0.4 per 100 000, a preference
for salivary glands and female individuals, and a tendency to
spread alongside nerve tracts. Moreover, its slow but steady
growth delays diagnosis and comes along with frequent
recurrence and metastasis, reducing by half the survival rates
between 5 and 15 years.6 ACC occurring in the external audi-
tory canal (EAC) ranges about four orders of magnitude under
ACC incidence, that is to say that information is sparse,
misdiagnosis frequent, and a treatment consensus absent
[66,67].
Chen et al. decided to improve the limited amount of
available information with a retrospective review on twelve
b i om e d i c a l j o u r n a l 4 3 ( 2 0 2 0 ) 9 9e1 0 6104EAC AAC patients over 30 years from a single institution in
Taiwan, describing patient characteristics, symptoms, treat-
ments and outcomes. In conclusion, they advise to include
EAC AAC as a possible diagnostic for middle-aged women
with lasting ear pain and an EAC mass, as well as to closely
monitor the appearance of lung metastases [68].News and Perspectives
Help for Oddjob7 e fixing form and function by orthognathic
surgery of cleft lip and palate
The craniofacial development of the human embryo is a highly
complex process that takes place mainly during the first
trimester, and requires the correct formation and fusion of five
primitive tissue lobes [69]. Numerous genetic defects and
environmental factors can lead to defaults in the final fusion
steps, leading among others to a cleft lip and/or palate. Besides
problems with feeding, dental occlusion, speech and in-
fections, the condition entails a heavy psychosocial burden,
exemplified by the severely biased depiction of individuals
with an orofacial cleft as villains in works of fiction.8 Early
surgery usually achieves the re-establishment of functional
features and satisfying facial aesthetics. Nevertheless, both
goals can sometimes be conflicting. Multiple articles in the
recent issues of the Biomedical Journal have illustrated that the
patient's pre- and post-operative opinion and satisfaction are
more and more considered for orthognathic surgery [70,71].
Hence, Denadai et al. explain in this issue's editorial note how
three-dimensional imaging and computer-aided modelling of
the surgery outcome, in combination with the taking into
consideration of the patient's, or patient's family's, preferences
has improved the outcome of orthognathic orofacial cleft
surgery both in terms of functional and aesthetic outcome [72].Conflicts of interest
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